Bruker Corp - Current report filing (8-K)
28 February 2008 - 11:15PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
February 28,
2008
BRUKER CORPORATION
(Exact name of
registrant as specified in its charter)
Delaware
(State or other
jurisdiction
of incorporation)
|
|
000-30833
(Commission
File Number)
|
|
04-3110160
(IRS Employer
Identification No.)
|
|
|
|
|
|
40
Manning Road
Billerica, MA 01821
(Address of
principal executive offices)(Zip Code)
|
|
Registrants
telephone number, including area code:
(978) 663-3660
|
Check
the appropriate box if the Form 8-K filing is intended to simultaneously
satisfy the reporting obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act
|
|
|
o
|
Soliciting
material pursuant to Rule 14a-12 of the Exchange Act
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) Exchange Act
|
|
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) Exchange Act
|
Section 2
Financial Information
Item
2.02. Results of Operations and
Financial Condition
The information in this
Current Report on Form 8-K, including Exhibit 99.1 attached hereto,
is being furnished and shall not be deemed filed for purposes of Section 18 of the Securities Exchange
Act of 1934, as amended, and shall not be incorporated by reference into any
filing of the company under the Securities Act of 1933, as amended, except as
shall be expressly set forth by specific reference in such filing.
On February 28,
2008, Bruker Corporation (formerly known as Bruker BioSciences Corporation)
issued a press release announcing financial results as of and for the three and
twelve months ended December 31, 2007.
A copy of the press release is attached hereto as Exhibit 99.1.
2
Section 9
Financial Statements and Exhibits
Item
9.01. Financial Statements and Exhibits.
(d)
|
Exhibits
|
|
|
|
|
|
|
|
Number
|
|
|
|
|
|
99.1
|
Press release dated
February 28, 2008.
|
|
|
|
|
|
|
3
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
BRUKER CORPORATION
(Registrant)
|
|
|
Date: February 28,
2008
|
By:
|
|
/s/ Frank H.
Laukien
|
|
|
|
Frank H.
Laukien, Ph.D.
Chief Executive Officer and President
|
|
|
|
|
|
|
4
Exhibit Index
Exhibit
Number
|
|
Exhibit Name
|
|
Location
|
|
|
|
|
|
99.1
|
|
Press release dated February 28, 2008.
|
|
Furnished herewith*
|
*
Exhibit 99.1 attached hereto is being furnished
and shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that section, nor shall such information be deemed incorporated
by reference in any filing under the Securities Act of 1933, as amended, except
as shall be expressly set forth by specific reference in such filing.
5
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024